BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34816819)

  • 1. Polidocanol Sclerotherapy in Pyogenic Granulomas.
    Khurana A; Mathachan SR
    Dermatol Surg; 2022 Jan; 48(1):72-75. PubMed ID: 34816819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polidocanol Sclerotherapy for the Treatment of Pyogenic Granuloma in Children.
    Li J; Wu C; Song D; Wang L; Guo L
    Dermatol Surg; 2021 Jun; 47(6):802-804. PubMed ID: 33625133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of intralesional polidocanol sclerotherapy in the treatment of plantar warts: a pilot study.
    Eassa BI; Abdel-Hameed AKS; Ismail AIA
    Arch Dermatol Res; 2024 May; 316(6):204. PubMed ID: 38787466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary aneurysmal bone cysts.
    Puri A; Hegde P; Gulia A; Parikh M
    Bone Joint J; 2020 Feb; 102-B(2):186-190. PubMed ID: 32009434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3% Polidocanol Sclerotherapy for Pyogenic Granuloma: Efficacy and Safety Analysis.
    Deshpande AJ; Dubey VC
    J Cutan Aesthet Surg; 2022; 15(3):284-287. PubMed ID: 36561400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial.
    Mishra S; Sahoo AK; Elamurugan TP; Jagdish S
    Turk J Gastroenterol; 2020 May; 31(5):378-383. PubMed ID: 32519957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of polidocanol sclerotherapy in mucocele of the minor salivary gland.
    Liu JL; Zhang AQ; Jiang LC; Li KY; Liu FZ; Yuan DY; Xu K; Fan QC; Liu XB; Zou B; Meng Z; Feng Y; Zhang B
    J Oral Pathol Med; 2018 Oct; 47(9):895-899. PubMed ID: 29998466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Polidocanol sclerotherapy for the treatment of pyogenic granuloma.
    Carvalho RA; Neto V
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1068-70. PubMed ID: 20590716
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - A retrospective cohort study from a single tertiary medical center.
    Hou F; Chen J; Xia M; Ding K; Zeng Q; Liu W
    Medicine (Baltimore); 2020 Feb; 99(9):e18839. PubMed ID: 32118707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial.
    Nasser MM; Ghoneim BM; Eldaly W; Elmahdy H
    J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101874. PubMed ID: 38522666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
    Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Ultrasound-Guided Percutaneous Polidocanol Injection Versus Percutaneous Ethanol Injection for Treatment of Benign Cystic Thyroid Nodules.
    Gong X; Wang F; Du H; Chen X; Shi B
    J Ultrasound Med; 2018 Jun; 37(6):1423-1429. PubMed ID: 29219197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of male varicoceles by transcatheter polidocanol foam sclerotherapy: evaluation of clinical success, complications, and patients' satisfaction with regard to alternative techniques.
    Ali A; Wirth S; Treitl KM; Treitl M
    Eur Radiol; 2015 Oct; 25(10):2889-97. PubMed ID: 25796582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polidocanol (Varithena) for varicose veins.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):111-2. PubMed ID: 26218793
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous sclerotherapy of peripheral venous malformations in pediatric patients.
    Gulsen F; Cantasdemir M; Solak S; Gulsen G; Ozluk E; Numan F
    Pediatr Surg Int; 2011 Dec; 27(12):1283-7. PubMed ID: 21818522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.
    Mimura H; Fujiwara H; Hiraki T; Gobara H; Mukai T; Hyodo T; Iguchi T; Yasui K; Kimata Y; Kanazawa S
    Eur Radiol; 2009 Oct; 19(10):2474-80. PubMed ID: 19440712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polidocanol for endovenous microfoam sclerosant therapy.
    Eckmann DM
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Safety and Efficacy of Foam Sclerotherapy With 1: 2 Polidocanol to Air Ratio Versus 1: 4 Ratio for the Treatment of Reticular Veins of the Lower Extremities.
    Hoss E; Kollipara R; Boen M; Alhaddad M; Goldman MP
    Dermatol Surg; 2020 Dec; 46(12):1715-1720. PubMed ID: 32947299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of polidocanol sclerotherapy in alleviating symptoms in patients with venous malformations.
    Guzelbey T; Cingoz M; Erdim C; Mutlu IN; Kılıckesmez O
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101698. PubMed ID: 37890587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.